Changing the release kinetics of gentamicin from poly(D,L-lactide) implant coatings using only one polymer

International Journal of Artificial Organs

Volumn 34, Issue 3, 2011, Pages 304-316

  Strobel, Catrin ^a   Schmidmaier, Gerhard ^b   Wildemann, Britt ^a  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

Author keywords

Controlled drug release; Degradation; Erosion; Polylactic acid

Indexed keywords

BONE; DRUG PRODUCTS; KINETICS; PLASTIC COATINGS; POLYMERIC IMPLANTS; TARGETED DRUG DELIVERY; WIRE;

ANTIBIOTIC GENTAMICIN; COATED WIRES; CONTROLLED DRUG RELEASE; ELUTION KINETICS; L-LACTIDE; LOW CONCENTRATIONS; ORTHOPAEDIC IMPLANTS; POLYMER-SOLVENTS; RELEASE KINETICS; TITANIUM K-WIRES;

CONTROLLED DRUG DELIVERY;

DRUG CARRIER; GENTAMICIN; POLY(DEXTRO,LEVO LACTIDE); POLYMER; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED DRUG RELEASE; DRUG COATING; ELUTION; KIRSCHNER WIRE; SCANNING ELECTRON MICROSCOPY; STAPHYLOCOCCUS AUREUS; SUSTAINED DRUG RELEASE;

EID: 79955730695     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.5301/IJAO.2011.6470     Document Type: Article

References (42)

1. Hoffman AS. The origins and evolution of "controlled" drug delivery systems. J Control Release 2008; 132: 153-63.
2. Platé NA, Valuev LI. On the interaction of heparin-contain- ing polymers with plasma proteins and blood. Thromb Res 1982; 27: 131-41.
3. Schmidmaier G, Schwabe P, Strobel C, Wildemann B. Car- rier systems and application of growth factors in orthopae- dics. Injury 2008; 39 (Suppl 2): S37-43.
4. Schmidmaier G, Lucke M, Wildemann B, Haas NP, Raschke M. Prophylaxis and treatment of implant-related infections by antibiotic-coated implants: a review. Injury 2006; 37 (Sup- pl 2): S105-12.
5. Li J, Barrow D, Howell H, Kalachandra S. In vitro drug re- lease study of methacrylate polymer blend system: effect of polymer blend composition, drug loading and solubilizing surfactants on drug release. J Mater Sci Mater Med 2010; 21: 583-8.
6. Giteau A, Venier-Julienne MC, Aubert-Pouessel A, Benoit JP. How to achieve sustained and complete protein release from PLGA-based microparticles? Int J Pharm 2008; 350: 14-26.
7. Choi J, Konno T, Takai M, Ishihara K. Controlled drug re- lease from multilayered phospholipid polymer hydrogel on titanium alloy surface. Biomaterials 2009; 30: 5201-8.
8. He T, Chan V. Covalent layer-by-layer assembly of polyethyl- eneimine multilayer for antibacterial applications. J Biomed Mater Res A 2010; 95: 454-64.
9. Moskowitz JS, Blaisse MR, Samuel RE, et al. The effective- ness of the controlled release of gentamicin from polyelec- trolyte multilayers in the treatment of Staphylococcus au- reus infection in a rabbit bone model. Biomaterials 2010; 31: 6019-30.
10. Jeon JH, Puleo DA. Alternating release of different bioactive molecules from a complexation polymer system. Biomateri- als 2008; 29: 3591-8.
11. Adams CS, Antoci V Jr, Harrison G, et al. Controlled release of vancomycin from thin sol-gel films on implant surfaces successfully controls osteomyelitis. J Orthop Res 2009; 27: 701-9.
12. Koort JK, Makinen TJ, Suokas E, et al. Sustained release of ciprofloxacin from an osteoconductive poly(DL)-lactide im- plant. Acta Orthop 2008; 79: 295-301.
13. Yoon JJ, Chung HJ, Lee HJ, Park TG. Heparin-immobilized biodegradable scaffolds for local and sustained release of angiogenic growth factor. J Biomed Mater Res A 2006; 79: 934-42.
14. Woo BH, Fink BF, Page R, et al. Enhancement of bone growth by sustained delivery of recombinant human bone morphogenetic protein-2 in a polymeric matrix. Pharm Res 2001; 18: 1747-53.
15. Vert M. Degradable and bioresorbable polymers in surgery and in pharmacology: beliefs and facts. J Mater Sci Mater Med 2009; 20: 437-46.
16. Simamora P, Chern W. Poly-L-lactic acid: an overview. J Drugs Dermatol 2006; 5: 436-40.
17. Tsuji H, Miyauchi S. Enzymatic hydrolysis of poly(lactide)s: effects of molecular weight, L-lactide content, and enantio- meric and diastereoisomeric polymer blending. Biomacro- molecules 2001; 2: 597-604.
18. Teng X, Ren J, Gu S. Preparation and characterization of porous PDLLA/HA composite foams by supercritical carbon dioxide technology. J Biomed Mater Res B Appl Biomater 2007; 81: 185-93.
19. Jia L, Zheng JJ, Jiang SM, Huang KH. Preparation, physico- chemical characterization and cytotoxicity in vitro of gemcit- abine-loaded PEG-PDLLA nanovesicles. World J Gastroen- terol 2010; 16: 1008-13.
20. Nair LS, Laurencin CT. Biodegradable polymers as biomate- rials. Prog Polym Sci 2007;: 762-98.
21. Miao H, Fan Y, Liu Y, Liu Y, Hao J, Deng X. Biodegradable poly(sebacic anhydride-co-caprolactone) multi-block copo- lymers: Synthesis, characterization, crystallinity and crystal- line morphology. Eur Polym J 2007; 43: 1055-64.
22. Gollwitzer H, Thomas P, Diehl P, et al. Biomechanical and al- lergological characteristics of a biodegradable poly(d,l-lactic acid) coating for orthopaedic implants. J Orthop Res 2005; 23: 802-9.
23. Wildemann B, Sander A, Schwabe P, et al. Short term in vivo biocompatibility testing of biodegradable poly(D,L-lactide)- growth factor coating for orthopaedic implants. Biomaterials 2005; 26: 4035-40.
24. Greiner SH, Wildemann B, Back DA, et al. Local application of zoledronic acid incorporated in a poly(D,L-lactide)-coated implant accelerates fracture healing in rats. Acta Orthop 2008; 79: 717-25.
25. Greiner S, Kadow-Romacker A, Schmidmaier G, Wilde- mann B. Cocultures of osteoblasts and osteoclasts are in- fluenced by local application of zoledronic acid incorporated in a poly(D,L-lactide) implant coating. J Biomed Mater Res A 2009; 91: 288-95.
26. Pauly S, Luttosch F, Morawski M, Haas NP, Schmidmaier G, Wildemann B. Simvastatin locally applied from a biodegrad- able coating of osteosynthetic implants improves fracture healing comparable to BMP-2 application. Bone 2009; 45: 505-11.
27. Lamberg A, Schmidmaier G, Soballe K, Elmengaard B. Lo- cally delivered TGF-beta1 and IGF-1 enhance the fixation of titanium implants: a study in dogs. Acta Orthop 2006; 77: 799-805.
28. Kandziora F, Bail H, Schmidmaier G, et al. Bone morphogen- ic protein-2 application by a poly(D,L-lactide)-coated inter- bodycage: in vivo results of a new carrier for growth factors. J Neurosurg 2002; 97: 40-8.
29. Lucke M, Wildemann B, Sadoni S, et al. Systemic versus local application of gentamicin in prophylaxis of implant re- lated osteomyelitis in a rat model. Bone 2005; 36: 770-8.
30. Gollwitzer H, Ibrahim K, Meyer H, Mittelmeier W, Busch R, Stemberger A. Antibacterial poly(D,L-lactic acid) coating of medical implants using a biodegradable drug delivery tech- nology. J Antimicrob Chemother 2003; 51: 585-91.
31. Matl FD, Obermeier A, Repmann S, Friess W, Stemberger A, Kuehn KD. New anti-infective coatings of medical implants. Antimicrob Agents Chemother 2008; 52: 1957-63.
32. Strawhecker KE, Kumar SK, Douglas JF, Karim A. The Criti- cal Role of Solvent Evaporation on the Roughness of Spin- Cast Polymer Films. Macromolecules 2001; 34: 4669-72.
33. Zhao L, Chu PK, Zhang Y, Wu Z. Antibacterial coatings on titanium implants. J Biomed Mater Res B Appl Biomater 2009; 91: 470-80.
34. Melchels FP, Feijen J, Grijpma DW. A poly(D,L-lactide) resin for the preparation of tissue engineering scaffolds by stereo- lithography. Biomaterials 2009; 30: 3801-9.
35. Raghoebar GM, Liem RS, Bos RR, van der Wal JE, Vissink A. Resorbable screws for fixation of autologous bone grafts. Clin Oral Implants Res 2006; 17: 288-93.
36. Schmidmaier G, Wildemann B, Stemberger A, Haas NP, Raschke M. Biodegradable poly(D,L-lactide) coating of im- plants for continuous release of growth factors. J Biomed Mater Res 2001; 58: 449-55.
37. Zhang X, McAuley KB, Goosen MFA. Towards prediction of release profiles of antibiotics from coated poly(-lactide) cyl- inders. J Control Release 1995; 34: 175-9.
38. Rothstein SN, Federspiel WJ, Little SR. A unified mathemati- cal model for the prediction of controlled release from sur- face and bulk eroding polymer matrices. Biomaterials 2009; 30: 1657-64.
39. Göpferich A. Bioresorbable Polymers as Drug Delivery Sys- tems. In: Walenkamp G, ed. Biomaterials in Surgery. Stutt- gart-New York: Thieme, 1998: 121-7.
40. Ma D, McHugh AJ. The interplay of membrane formation and drug release in solution-cast films of polylactide poly- mers. Int J Pharm 2010; 388: 1-12.
41. Pitt CG, Gratzl MM, Kimmel GL, Surles J, Schindler A. Ali- phatic polyesters II. The degradation of poly (DL-lactide), poly (epsilon-caprolactone), and their copolymers in vivo. Biomaterials 1981; 2: 215-20.
42. Tarvainen T, Malin M, Barragan I, Tuominen J, Seppala J, Jarvinen K. Effects of incorporated drugs on degradation of novel 2,2'-bis(2-oxazoline) linked poly(lactic acid) films. Int J Pharm 2006; 310: 162-7.